Cencora Falls on 1Q Revenue Miss

Dow Jones

Feb 05

By Elias Schisgall

Shares of Cencora fell after the company's revenue in the fiscal first quarter came in below Wall Street expectations.

Cencora shares fell 6.9% to $336.64 in Wednesday morning trading. The stock has risen 34% in the past 12 months.

The pharmaceutical distribution company on Wednesday reported a profit of $559.6 million, or $2.87 a share, compared with a profit of $488.6 million, or $2.50 a share, a year earlier.

On an adjusted basis, the company posted earnings of $4.08 a share. Analysts polled by FactSet were expecting $4.05 a share.

Revenue rose 5.5% to $85.93 billion, up from $81.49 billion a year earlier but behind analysts' expectations of $86.01 billion, according to FactSet.

The company raised its fiscal 2026 outlook for adjusted operating income to between 11.5% and 13.5% growth, up from a previous range of 8% to 10%, to reflect the company's acquisition of OneOncology and growth in the U.S. Healthcare Solutions segment.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

February 04, 2026 11:17 ET (16:17 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2609983396"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2609983396\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2609983396?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 00:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609983396","market":"sg","top_or_hot":-1,"title":"Cencora Falls on 1Q Revenue Miss","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Cencora fell after the company's revenue in the fiscal first quarter came in below Wall Street expectations. \n</p>\n<p>\n  Cencora shares fell 6.9% to $336.64 in Wednesday morning trading. The stock has risen 34% in the past 12 months. \n</p>\n<p>\n  The pharmaceutical distribution company on Wednesday reported a profit of $559.6 million, or $2.87 a share, compared with a profit of $488.6 million, or $2.50 a share, a year earlier. \n</p>\n<p>\n  On an adjusted basis, the company posted earnings of $4.08 a share. Analysts polled by FactSet were expecting $4.05 a share. \n</p>\n<p>\n  Revenue rose 5.5% to $85.93 billion, up from $81.49 billion a year earlier but behind analysts' expectations of $86.01 billion, according to FactSet. \n</p>\n<p>\n  The company raised its fiscal 2026 outlook for adjusted operating income to between 11.5% and 13.5% growth, up from a previous range of 8% to 10%, to reflect the company's acquisition of OneOncology and growth in the U.S. Healthcare Solutions segment. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 04, 2026 11:17 ET (16:17 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cencora Falls on 1Q Revenue Miss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCencora Falls on 1Q Revenue Miss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-05 00:17</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Cencora fell after the company's revenue in the fiscal first quarter came in below Wall Street expectations. \n</p>\n<p>\n  Cencora shares fell 6.9% to $336.64 in Wednesday morning trading. The stock has risen 34% in the past 12 months. \n</p>\n<p>\n  The pharmaceutical distribution company on Wednesday reported a profit of $559.6 million, or $2.87 a share, compared with a profit of $488.6 million, or $2.50 a share, a year earlier. \n</p>\n<p>\n  On an adjusted basis, the company posted earnings of $4.08 a share. Analysts polled by FactSet were expecting $4.05 a share. \n</p>\n<p>\n  Revenue rose 5.5% to $85.93 billion, up from $81.49 billion a year earlier but behind analysts' expectations of $86.01 billion, according to FactSet. \n</p>\n<p>\n  The company raised its fiscal 2026 outlook for adjusted operating income to between 11.5% and 13.5% growth, up from a previous range of 8% to 10%, to reflect the company's acquisition of OneOncology and growth in the U.S. Healthcare Solutions segment. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 04, 2026 11:17 ET (16:17 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2237957902.USD","symbol_name":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2609983396","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609983396","pubTimestamp":1770221820,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Cencora fell after the company's revenue in the fiscal first quarter came in below Wall Street expectations.Cencora shares fell 6.9% to $336.64 in Wednesday morning trading. The stock has risen 34% in the past 12 months.The pharmaceutical distribution company on Wednesday reported a profit of $559.6 million, or $2.87 a share, compared with a profit of $488.6 million, or $2.50 a share, a year earlier.On an adjusted basis, the company posted earnings of $4.08 a share. Analysts polled by FactSet were expecting $4.05 a share.Revenue rose 5.5% to $85.93 billion, up from $81.49 billion a year earlier but behind analysts' expectations of $86.01 billion, according to FactSet.The company raised its fiscal 2026 outlook for adjusted operating income to between 11.5% and 13.5% growth, up from a previous range of 8% to 10%, to reflect the company's acquisition of OneOncology and growth in the U.S. Healthcare Solutions segment.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU1119994496.HKD":"FIDELITY WORLD \"A\" (HKD) ACC","COR":"CENCORA","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","BK4585":"ETF&股票定投概念","LU1261432733.SGD":"Fidelity World A-ACC-SGD","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","BK4175":"保健护理产品经销商","LU0058720904.USD":"联博国际健康护理基金A","BK4529":"IDC概念","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","BK4588":"碎股","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4084":"特种房地产投资信托","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1814569148.SGD":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC"},"translate_title":"Cencora因第一季度收入未达预期而下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COR":0.9},"content_text":"By Elias Schisgall \n\n\n \n\n\n  Shares of Cencora fell after the company's revenue in the fiscal first quarter came in below Wall Street expectations. \n\n\n  Cencora shares fell 6.9% to $336.64 in Wednesday morning trading. The stock has risen 34% in the past 12 months. \n\n\n  The pharmaceutical distribution company on Wednesday reported a profit of $559.6 million, or $2.87 a share, compared with a profit of $488.6 million, or $2.50 a share, a year earlier. \n\n\n  On an adjusted basis, the company posted earnings of $4.08 a share. Analysts polled by FactSet were expecting $4.05 a share. \n\n\n  Revenue rose 5.5% to $85.93 billion, up from $81.49 billion a year earlier but behind analysts' expectations of $86.01 billion, according to FactSet. \n\n\n  The company raised its fiscal 2026 outlook for adjusted operating income to between 11.5% and 13.5% growth, up from a previous range of 8% to 10%, to reflect the company's acquisition of OneOncology and growth in the U.S. Healthcare Solutions segment. \n\n\n \n\n\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 04, 2026 11:17 ET (16:17 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}